Vingraf 0.5 Capsule
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Tacrolimus (0.5mg)
Overview Vingraf 0.5 Capsule
Post-transplant, Vingraf 0.5 Capsules, used in conjunction with other medications, help prevent organ rejection (e.g., liver, kidney, heart). By suppressing the immune system, it prevents the body from attacking the new organ. This immunosuppressant's dosage and frequency depend on the transplant type, body weight, and other concurrent medications; adhere strictly to your physician's instructions. Administer on an empty stomach, at least one hour before or two hours after eating. Consistent use maximizes benefits; discontinuation elevates organ rejection risk. Vingraf 0.5 Capsules carry potential side effects, including exacerbation or onset of diabetes and kidney issues—requiring immediate medical attention. Other common side effects: tremors, infections, hypertension, headaches, and sleep disturbances. Report persistent or worsening side effects to your doctor. Immunosuppression increases infection susceptibility. Inform your doctor of pre-existing kidney, liver, or heart conditions, diabetes, or hypertension before starting treatment. Disclose all other medications, particularly those for infections, pain, or arthritis, as interactions may occur. Minimize sun and UV exposure due to increased skin cancer risk. Reliable contraception is crucial for both men and women. Use during pregnancy or breastfeeding is generally discouraged unless medically essential. Regular medical check-ups, including frequent blood pressure monitoring, are necessary throughout treatment.
Primary Ingredients of Vingraf 0.5 Capsule
No information provided. Unable to rephrase.
Uses of Vingraf 0.5 Capsule
Preventing organ transplant rejection
Major Benefits of Vingraf 0.5 Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Vingraf 0.5 Capsule on an empty stomach.
Common Side effects of Vingraf 0.5 Capsule:
- High blood pressure
- Increased glucose level in blood
- Kidney damage
- Insomnia (difficulty in sleeping)
- Tremors
- Headache
- Abnormal liver function tests
- Infection
How to use Vingraf 0.5 Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Vingraf 0.5 Capsule on an empty stomach.
How Vingraf 0.5 Capsule works:
Immunosuppressant Vingraf 0.5 Capsule reduces the body's immune reaction after organ transplantation (such as liver, kidney, or heart). This action facilitates the body's acceptance of the transplanted organ.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Vingraf 0.5 Capsule is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vingraf 0.5 Capsule during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Vingraf 0.5 Capsule are likely incompatible. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Vingraf 0.5 Capsules might cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Vingraf 0.5 Capsule cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Vingraf 0.5 Capsule cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Vingraf 0.5 Capsule :
Should you forget to take a Vingraf 0.5 Capsule, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vingraf 0.5 Capsule
| Label | Value |
|---|---|
| Chemical Type | Macrolide-Lactam Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |



